(4′-(Pentyloxy)-[1,1′-biphenyl]-4-yl)boronic acid

We are (4′-(Pentyloxy)-[1,1′-biphenyl]-4-yl)boronic acid CAS:158937-25-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: (4'-(Pentyloxy)-[1,1'-biphenyl]-4-yl)boronic acid
Other Name:
(4'-(Pentyloxy)-[1,1'-biphenyl]-4-yl)boronic acid
[4-(4-pentoxyphenyl)phenyl]boronic acid
[4'-(Pentyloxy)-4-biphenylyl]boronic acid
CAS No: 158937-25-8
MF: C17H21BO3
MW: 284.15800
Density: 1.1±0.1 g/cm3
Boiling point: 459.9±55.0 °C at 760 mmHg
Melting point: 197°C(lit.)
Flash point: 231.9±31.5 °C
Refractive index: 1.565
UN Number: NA
UN Proper Shipping Name: NA
Transport hazard class: NA
Packing group: NA
 
Specification
Appearance: White powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Applicationd as an intermediate of Anidulafungin.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

(4'-(Pentyloxy)-[1,1'-biphenyl]-4-yl)boronic acid


Related News: Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as “bulk pharmaceutical chemicals (BPCs).”arsorosomethane CAS:593-58-8 Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations.Acetoacet-p-phenetidide CAS:122-82-7 Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations.3-Cyanophenylboronic acid The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities.

Related Products
Product Name
5-Ethyl-2-[2-(4-nitrophenoxy)ethyl]pyridine View Details
bis(2-diphenylphosphanylethyl)-phenylphosphane View Details
N,N’-Bis(9-Fluorenylmethyloxycarbonyl)-L-Histidine View Details
Methyl isobutyryl acetate manufacturer N-Fmoc-L-Threonol manufacturer 2,5-DIBROMO-6-METHYLPYRIDINE manufacturer 2-(1H-1,2,4-Triazol-1-yl)-2′,4′-difluoroacetophenone manufacturer 2,2′-(5-(Bromomethyl)-1,3-phenylene)bis(2-methylpropanenitrile) manufacturer